Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Chen, Te Chuan ^a   Sung, Mao Ling ^b   Kuo, Hsing Chun ^c   Chien, Shao Ju ^a   Yen, Chia Kuang ^b   Chen, Cheng Nan ^d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b St Martin De Porres Hospital   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1A; MICRORNA; MICRORNA 17; MICRORNA 221; PROTEIN; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG; CULTURE MEDIUM; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LYMPHOKINE; MIRN17 MICRORNA, HUMAN; MIRN221 MICRORNA, HUMAN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR C;

ADULT; AORTA MEDIA; ARTERY WALL; ARTICLE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DOWN REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; AORTA; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHARMACOLOGY; VASCULAR SMOOTH MUSCLE;

ADULT; AORTA; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOKINES; MACROPHAGES; MICRORNAS; MIDDLE AGED; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-SIS;

EID: 84915822025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113752     Document Type: Article

References (39)

1. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107: 1058-1070.
2. Rask-Madsen C, King GL (2013) Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17: 20-33
3. Liang CP, Han S, Senokuchi T, Tall AR (2007) The macrophage at the crossroads of insulin resistance and atherosclerosis. Circ Res 100: 1546-1555.
4. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE (2007) Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 100: 769-781.
5. Shanmugam N, Reddy MA, Guha M, Natarajan R (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256-1264.
6. Chen TC, Chien SJ, Kuo HC, Huang WS, Sheen JM, et al. (2011) High glucose-treated macrophages augment E-selectin expression in endothelial cells. J Biol Chem 286: 25564-25573.
7. Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB (2012) The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 95: 194-204.
8. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801.
9. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86: 515-581.
10. Raines EW (2004) PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15: 237-254.
11. Ahuja P, Sdek P, MacLellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87: 521-544.
12. Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, et al. (2011) Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol 31: 851-860.
13. Bornfeldt KE, Tabas I (2011) Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 14: 575-585.
14. Jeong IK, Oh da H, Park SJ, Kang JH, Kim S, et al. (2011) Inhibition of NF-kB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Exp Mol Med 43: 684-692.
15. Cai Q, Lanting L, Natarajan R (2004) Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. Am J Physiol Cell Physiol 287: C707-714.
16. Proudfoot D, Fitzsimmons C, Torzewski J, Bowyer DE (1999) Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: a co-culture study. Atherosclerosis 145: 157-165.
17. Schubert SY, Benarroch A, Ostvang J, Edelman ER (2008) Regulation of endothelial cell proliferation by primary monocytes. Arterioscler Thromb Vasc Biol 28: 97-104.
18. Chung JH, Jeon HJ, Hong SY, Lee da L, Lee KH, et al. (2012) Palmitate promotes the paracrine effects of macrophages on vascular smooth muscle cells: the role of bone morphogenetic proteins. PLoS One 7: e29100.
19. Chen CN, Li YS, Yeh YT, Lee PL, Usami S, et al. (2006) Synergistic roles of platelet-derived growth factor-BB and interleukin-1b in phenotypic modulation of human aortic smooth muscle cells. Proc Natl Acad Sci U S A 103: 2665-2670.
20. Robinson HC, Baker AH (2012) How do microRNAs affect vascular smooth muscle cell biology? Curr Opin Lipidol 23: 405-411.
21. Osório J (2010) Diabetes: Severe hypoglycemia associated with risk of vascular events and death. Nat Rev Cardiol 7: 666.
22. Askari B, Renard CB, Bornfeldt KE (2002) Regulation of smooth muscle cell accumulation in diabetes-accelerated atherosclerosis. Histol Histopathol 17: 1317-1328.
23. Matsumoto T, Kobayashi T, Kamata K (2010) Diabetic conditions act as matchmaker for monocytes and vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 298: H731-733.
24. Febbraio M, Hajjar DP, Silverstein RL (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791.
25. Yu S, Xi Z, Hai-Yan C, Ya-Li C, Shao-Hu X, et al. (2012) Interferon regulatory factor-1 as a positive regulator for high glucose-induced proliferation of vascular smooth muscle cells. J Cell Biochem 113: 2671-2678.
26. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE (2001) Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 50: 851-860.
27. Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, et al. (2001) Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 103: 2980-2986.
28. Peiró C, Lafuente N, Matesanz N, Cercas E, Llergo JL, et al. (2001) High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br J Pharmacol 133: 967-974.
29. Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, et al. (2000) Differential effects of the cyclin-dependent kinase inhibitors p27Kip1, p21Cip1, and p16Ink4 on vascular smooth muscle cell proliferation. Circulation 101: 2022-2025
30. Li P, Zhu N, Yi B, Wang N, Chen M, et al. (2013) MicroRNA-663 Regulates Human Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Neointimal Formation. Circ Res 113: 1117-1127.
31. Sun Y, Chen D, Cao L, Zhang R, Zhou J, et al. (2013) MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-a. Cardiovasc Res 100: 272-279.
32. Liu X, Cheng Y, Chen X, Yang J, Xu L, et al. (2011) MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 286: 42371-42380.
33. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, et al. (2008) The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9: R127.
34. Ballarino M, Jobert L, Dembélé D, de la Grange P, Auboeuf D, et al. (2013) TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs. Oncogene 32: 4646-4655.
35. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, et al. (2009) A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487.
36. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2009) Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284: 3728-3738.
37. Chiang JK, Sung ML, Yu HR, Chang HI, Kuo HC, et al. (2011) Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression. J Cell Physiol 226: 1017-1026.
38. Lee MJ, Kim MY, Heo SC, Kwon YW, Kim YM, et al. (2012) Macrophages regulate smooth muscle differentiation of mesenchymal stem cells via a prostaglandin F2a-mediated paracrine mechanism. Arterioscler Thromb Vasc Biol 32: 2733-2740.
39. Askari B, Carroll MA, Capparelli M, Kramer F, Gerrity RG, et al. (2002) Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J Biol Chem 277: 36338-36344.